Statins Reduce Delirium Risk in Older Adults With Type 2 Diabetes
- 22 February 2025
- journal article
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 26 (4) , 105490
Abstract
No abstract availableKeywords
Funding Information
- Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital
- National Key Research and Development Program of China (2023YFC2506900)
This publication has 43 references indexed in Scilit:
- Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort studyEuropean Journal of Clinical Pharmacology, 2023
- Association between long-term opioid use and cancer risk in patients with chronic pain: a propensity score-matched cohort studyBritish Journal of Anaesthesia, 2022
- Effect of opioids on cancer survival in patients with chronic pain: a propensity score-matched population-based cohort studyBritish Journal of Anaesthesia, 2022
- Association of Delirium With Long-term Cognitive DeclineJAMA Neurology, 2020
- A Selective Review of Negative Control Methods in EpidemiologyCurrent Epidemiology Reports, 2020
- Neurocognitive impairment in type 2 diabetes mellitusHormones, 2019
- Statins and Delirium: Is There a Role?Current Atherosclerosis Reports, 2014
- Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysisDiabetologia, 2014
- Neuroprotective Effects of Statins: Evidence from Preclinical and Clinical StudiesCurrent Treatment Options in Cardiovascular Medicine, 2012
- Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysisDiabetes Research and Clinical Practice, 2010